OBJECTIVE: To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls. DESIGN: Prospective cohort study. SETTING: 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom. PARTICIPANTS: 2817 schoolgirls in year 8 (12 and 13 year olds). INTERVENTION: Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year. MAIN OUTCOME MEASURES: Vaccine uptake for doses 1 and 2 of a three dose schedule. RESULTS: Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second dose. Uptake was significantly lower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported. CONCLUSION: Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.
OBJECTIVE: To assess the feasibility and acceptability of delivering a human papillomavirus (HPV) vaccine to adolescent girls. DESIGN: Prospective cohort study. SETTING: 36 secondary schools in two primary care trusts in Greater Manchester, United Kingdom. PARTICIPANTS: 2817 schoolgirls in year 8 (12 and 13 year olds). INTERVENTION: Delivery of the bivalent vaccine at 0, 1, and 6 months over one school year. MAIN OUTCOME MEASURES: Vaccine uptake for doses 1 and 2 of a three dose schedule. RESULTS: Vaccine uptake was 70.6% (1989/2817) for the first dose and 68.5% (1930/2817) for the second dose. Uptake was significantly lower in schools with a higher proportion of ethnic minority girls (P<0.001 for trend) or higher proportion of girls entitled to free school meals (P=0.029 for trend). The main reason for parents' refusal of vaccination was insufficient information about the vaccine and its long term safety. Maintaining the vaccine schedule was challenging as 16.3% (dose 1) and 23.6% (dose 2) of girls missed their vaccination day and had to be offered alternative appointments. No serious adverse events were reported. CONCLUSION: Delivery of the first two doses of HPV vaccine to adolescent schoolgirls is encouraging, but the success of the vaccination programme depends on high coverage for the third dose.
Authors: L A Wallace; J C Bramley; S Ahmed; R Duff; S J Hutchinson; W F Carman; N R E Kitchin; D J Goldberg Journal: Arch Dis Child Date: 2004-11 Impact factor: 3.791
Authors: Gregory D Zimet; Nicole Liddon; Susan L Rosenthal; Eduardo Lazcano-Ponce; Betania Allen Journal: Vaccine Date: 2006-08-31 Impact factor: 3.641
Authors: M Kohli; N Ferko; A Martin; E L Franco; D Jenkins; S Gallivan; C Sherlaw-Johnson; M Drummond Journal: Br J Cancer Date: 2006-12-05 Impact factor: 7.640
Authors: Paul L Reiter; Annie-Laurie McRee; Jessica K Pepper; Kim Chantala; Noel T Brewer Journal: J Adolesc Health Date: 2012-03-15 Impact factor: 5.012
Authors: Jessica A Nodulman; Randall Starling; Alberta S Kong; David B Buller; Cosette M Wheeler; W Gill Woodall Journal: J Sch Health Date: 2015-05 Impact factor: 2.118